Cargando…
Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease
Krabbe's disease is an infantile neurodegenerative disease, which is affected by mutations in the lysosomal enzyme galactocerebrosidase, leading to the accumulation of its metabolite psychosine. We have shown previously that the S1P receptor agonist fingolimod (FTY720) attenuates psychosine-ind...
Autores principales: | Béchet, Sibylle, O'Sullivan, Sinead A., Yssel, Justin, Fagan, Steven G., Dev, Kumlesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141882/ https://www.ncbi.nlm.nih.gov/pubmed/32127495 http://dx.doi.org/10.1523/JNEUROSCI.2346-19.2020 |
Ejemplares similares
-
Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease
por: Fagan, Steven G., et al.
Publicado: (2022) -
The Effects of Antipsychotics in Experimental Models of Krabbe Disease
por: Sharma, Kapil, et al.
Publicado: (2023) -
Fingolimod Attenuates Splenocyte-Induced Demyelination in Cerebellar Slice Cultures
por: Pritchard, Adam J., et al.
Publicado: (2014) -
The chemokine fractalkine (CX3CL1) attenuates H(2)O(2)-induced demyelination in cerebellar slices
por: O’Sullivan, Sinead A., et al.
Publicado: (2017) -
Phospholipase A2 is involved in galactosylsphingosine-induced astrocyte toxicity, neuronal damage and demyelination
por: Misslin, Cedric, et al.
Publicado: (2017)